ReviewCardiology research and practice2026
Prognostic Associations of the Naples Score for Clinical Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and a Prognostic Meta-Analysis.
Review in Cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Naples Prognostic Score (NPS) is a composite inflammatory-nutritional index that integrates serum albumin, total cholesterol, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio to predict outcomes in acute myocardial infarction (MI); however, its independent prognostic value remains incompletely defined. Objective: To assess the correlation between the NPS and outcomes in patients with acute MI. Methods: We searched PubMed, Scopus, Cochrane, Embase, and Wiley Online Library for studies evaluating the NPS in patients with acute MI. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models, and heterogeneity was assessed using the I Results: Nine observational cohort studies comprising 15,998 patients with MI were analyzed. Higher NPS was associated with increased odds of all-cause mortality (OR 3.31; 95% CI: 1.62-6.77, Conclusion: Higher NPS was correlated with higher risk of all-cause mortality, no-reflow phenomenon, and new-onset atrial fibrillation in patients with acute MI. All estimates are based on observational data that have not been adjusted for any factors; there were three to four cohorts per outcome, and eight of nine studies were from one country. The findings are exploratory and do not warrant the use of NPS as a clinical risk stratification tool; future, adjusted, multinational validation is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.